The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
BACKGROUND:The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). However, the anxiety regarding PQ-i...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2019
|
_version_ | 1797053432821972992 |
---|---|
author | Dysoley, L Kim, S Lopes, S Khim, N Bjorges, S Top, S Huch, C Rekol, H Westercamp, N Fukuda, M Hwang, J Roca-Feltrer, A Mukaka, M Menard, D Taylor, W |
author_facet | Dysoley, L Kim, S Lopes, S Khim, N Bjorges, S Top, S Huch, C Rekol, H Westercamp, N Fukuda, M Hwang, J Roca-Feltrer, A Mukaka, M Menard, D Taylor, W |
author_sort | Dysoley, L |
collection | OXFORD |
description | BACKGROUND:The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). However, the anxiety regarding PQ-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency (G6PDd) has hindered its use. Therefore, we assessed the tolerability of SLDPQ in Cambodia to inform national policy. METHODS:This open randomised trial of dihydroartemisinin-piperaquine (DHAPP) + SLDPQ vs. DHAPP alone recruited Cambodians aged ≥1 year with acute uncomplicated P. falciparum. Randomisation was 4:1 DHAPP+SLDPQ: DHAPP for G6PDd patients and 1:1 for G6PDn patients, according to the results of the qualitative fluorescent spot test. Definitive G6PD status was determined by genotyping. Day (D) 7 haemoglobin (Hb) concentration was the primary outcome measure. RESULTS:One hundred nine patients (88 males, 21 females), aged 4-76 years (median 23) were enrolled; 12 were G6PDd Viangchan (9 hemizygous males, 3 heterozygous females). Mean nadir Hb occurred on D7 [11.6 (range 6.4 ─ 15.6) g/dL] and was significantly lower (p = 0.040) in G6PDd (n = 9) vs. G6PDn (n = 46) DHAPP+SLDPQ recipients: 10.9 vs. 12.05 g/dL, Δ = -1.15 (95% CI: -2.24 ─ -0.05) g/dL. Three G6PDn patients had D7 Hb concentrations < 8 g/dL; D7-D0 Hbs were 6.4 ─ 6.9, 7.4 ─ 7.4, and 7.5 ─ 8.2 g/dL. For all patients, mean (range) D7-D0 Hb decline was -1.45 (-4.8 ─ 2.4) g/dL, associated significantly with higher D0 Hb, higher D0 parasitaemia, and receiving DHAPP; G6PDd was not a factor. No patient required a blood transfusion. CONCLUSIONS:DHAPP+SLDPQ was associated with modest Hb declines in G6PD Viangchan, a moderately severe variant. Our data augment growing evidence that SLDPQ in SE Asia is well tolerated and appears safe in G6PDd patients. Cambodia is now deploying SLDPQ and this should encourage other GMS countries to follow suit. TRIAL REGISTRATION:The clinicaltrials.gov reference number is NCT02434952 . |
first_indexed | 2024-03-06T18:43:39Z |
format | Journal article |
id | oxford-uuid:0dc318eb-9fce-4dfe-8b01-d505c70f3889 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T18:43:39Z |
publishDate | 2019 |
publisher | BioMed Central |
record_format | dspace |
spelling | oxford-uuid:0dc318eb-9fce-4dfe-8b01-d505c70f38892022-03-26T09:42:14ZThe tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected CambodiansJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0dc318eb-9fce-4dfe-8b01-d505c70f3889EnglishSymplectic Elements at OxfordBioMed Central2019Dysoley, LKim, SLopes, SKhim, NBjorges, STop, SHuch, CRekol, HWestercamp, NFukuda, MHwang, JRoca-Feltrer, AMukaka, MMenard, DTaylor, WBACKGROUND:The WHO recommends single low-dose primaquine (SLDPQ, 0.25 mg/kg body weight) in falciparum-infected patients to block malaria transmission and contribute to eliminating multidrug resistant Plasmodium falciparum from the Greater Mekong Sub region (GMS). However, the anxiety regarding PQ-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase deficiency (G6PDd) has hindered its use. Therefore, we assessed the tolerability of SLDPQ in Cambodia to inform national policy. METHODS:This open randomised trial of dihydroartemisinin-piperaquine (DHAPP) + SLDPQ vs. DHAPP alone recruited Cambodians aged ≥1 year with acute uncomplicated P. falciparum. Randomisation was 4:1 DHAPP+SLDPQ: DHAPP for G6PDd patients and 1:1 for G6PDn patients, according to the results of the qualitative fluorescent spot test. Definitive G6PD status was determined by genotyping. Day (D) 7 haemoglobin (Hb) concentration was the primary outcome measure. RESULTS:One hundred nine patients (88 males, 21 females), aged 4-76 years (median 23) were enrolled; 12 were G6PDd Viangchan (9 hemizygous males, 3 heterozygous females). Mean nadir Hb occurred on D7 [11.6 (range 6.4 ─ 15.6) g/dL] and was significantly lower (p = 0.040) in G6PDd (n = 9) vs. G6PDn (n = 46) DHAPP+SLDPQ recipients: 10.9 vs. 12.05 g/dL, Δ = -1.15 (95% CI: -2.24 ─ -0.05) g/dL. Three G6PDn patients had D7 Hb concentrations < 8 g/dL; D7-D0 Hbs were 6.4 ─ 6.9, 7.4 ─ 7.4, and 7.5 ─ 8.2 g/dL. For all patients, mean (range) D7-D0 Hb decline was -1.45 (-4.8 ─ 2.4) g/dL, associated significantly with higher D0 Hb, higher D0 parasitaemia, and receiving DHAPP; G6PDd was not a factor. No patient required a blood transfusion. CONCLUSIONS:DHAPP+SLDPQ was associated with modest Hb declines in G6PD Viangchan, a moderately severe variant. Our data augment growing evidence that SLDPQ in SE Asia is well tolerated and appears safe in G6PDd patients. Cambodia is now deploying SLDPQ and this should encourage other GMS countries to follow suit. TRIAL REGISTRATION:The clinicaltrials.gov reference number is NCT02434952 . |
spellingShingle | Dysoley, L Kim, S Lopes, S Khim, N Bjorges, S Top, S Huch, C Rekol, H Westercamp, N Fukuda, M Hwang, J Roca-Feltrer, A Mukaka, M Menard, D Taylor, W The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians |
title | The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians |
title_full | The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians |
title_fullStr | The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians |
title_full_unstemmed | The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians |
title_short | The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians |
title_sort | tolerability of single low dose primaquine in glucose 6 phosphate deficient and normal falciparum infected cambodians |
work_keys_str_mv | AT dysoleyl thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT kims thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT lopess thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT khimn thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT bjorgess thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT tops thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT huchc thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT rekolh thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT westercampn thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT fukudam thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT hwangj thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT rocafeltrera thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT mukakam thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT menardd thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT taylorw thetolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT dysoleyl tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT kims tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT lopess tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT khimn tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT bjorgess tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT tops tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT huchc tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT rekolh tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT westercampn tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT fukudam tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT hwangj tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT rocafeltrera tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT mukakam tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT menardd tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians AT taylorw tolerabilityofsinglelowdoseprimaquineinglucose6phosphatedeficientandnormalfalciparuminfectedcambodians |